Ningmitai capsule

DRUG4 trials

Sponsors

Xintian Pharmaceutical

Conditions

Chronic ProstatitisChronic Prostatitis With Chronic Pelvic Pain SyndromeErectile DysfunctionUreteral Calculi

Phase 4

Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome

CompletedNCT05890235

Xintian PharmaceuticalChronic Prostatitis

Start: 2018-11-16End: 2022-07-10Updated: 2023-06-06

Clinical Observation of Ningmitai Capsule in Treating Chronic Pelvic Pain Syndrome With Erectile Dysfunction

CompletedNCT06064448

Xintian PharmaceuticalChronic Prostatitis With Chronic Pelvic Pain Syndrome, Erectile Dysfunction

Start: 2019-03-19End: 2022-12-22Updated: 2023-10-12

Clinical Study of Ningmitai Capsule on Promoting the Passage of Residual Fragments After Ureteroscopic Lithotripsy

CompletedNCT06105827

Xintian PharmaceuticalUreteral Calculi

Start: 2016-10-02End: 2019-04-25Updated: 2023-10-30

Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in the Treatment of CP/CPPS

CompletedNCT06159114

Xintian PharmaceuticalChronic Prostatitis

Start: 2023-12-19End: 2025-01-31Updated: 2026-07-27

Related Papers

Ningmitai capsule in patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, prospective, randomized, parallel, positive-controlled study.

2025-12-03

The efficacy of combination therapy with Ningmitai capsule and sildenafil in men with chronic prostatitis/chronic pelvic pain syndrome and erectile dysfunction: a prospective, multicenter, randomized controlled trial

Sexual Medicine2025-04-011 citations